Recombinant Clostridium botulinum Elongation factor G (fusA), partial

Shipped with Ice Packs
In Stock

Description

Definition and Biological Role

Elongation factor G (EF-G) is a GTPase essential for ribosomal translocation during protein synthesis and ribosome recycling . In C. botulinum, EF-G (encoded by fusA) is hypothesized to support bacterial survival and toxin production, though its direct role in botulinum neurotoxin (BoNT) activity remains unclear . The recombinant "partial" EF-G refers to a truncated form (amino acids 1-689) expressed in heterologous systems like E. coli for research and therapeutic applications .

Applications in Vaccine Development

While most C. botulinum vaccines target BoNT’s receptor-binding domain (HC) , recombinant EF-G offers a novel strategy to combat bacterial colonization or persistence.

Comparative Analysis of C. botulinum Vaccine Candidates:

AntigenTarget ComponentExpression SystemProtective Efficacy (LD₅₀)Citation
Recombinant HC (BoNT/F)Neurotoxin domainE. coli20,000 LD₅₀ PMC2593168
Recombinant EF-G (fusA)Translational machineryE. coli/YeastUnder investigation Creative Biolabs
rHC CB-L-HC CADual BoNT/A + BE. coli10⁵ LD₅₀ (A), 10³ LD₅₀ (B) PMC10171130

Rationale for EF-G as a Vaccine Target:

  • Conservation: EF-G is highly conserved across bacterial species, enabling broad-spectrum potential .

  • Surface Exposure: Domain II’s ribosomal interaction sites may elicit neutralizing antibodies .

Research Findings and Challenges

  • Expression Systems: The partial EF-G is produced in E. coli, yeast, or mammalian cells, with yields and purity tailored for immunological assays .

  • Immunogenicity: Preliminary data suggest EF-G triggers antibody responses in preclinical models, though neutralizing capacity against C. botulinum remains unverified .

  • Functional Trade-offs: Truncation (aa 1-689) may limit antigenic epitopes compared to full-length EF-G, necessitating adjuvant optimization .

Future Directions

  • Mechanistic Studies: Clarify EF-G’s role in C. botulinum pathogenicity and toxin regulation.

  • Adjuvant Synergy: Test EF-G with alum or TLR agonists to enhance immunogenicity .

  • Cross-Protection: Evaluate efficacy against multiple Clostridium species .

Product Specs

Form
Lyophilized powder. We will ship the available format, but if you have special format requirements, please note them when ordering.
Lead Time
Delivery time varies by purchase method and location. Consult local distributors for specific delivery times. Proteins are shipped with blue ice packs by default. Contact us in advance for dry ice shipment (extra fees apply).
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
fusA; CLL_A0235Elongation factor G; EF-G
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Clostridium botulinum (strain Eklund 17B / Type B)
Target Names
fusA
Uniprot No.

Target Background

Function
Catalyzes the GTP-dependent ribosomal translocation step during translation elongation. The ribosome transitions from the pre-translocational (PRE) to the post-translocational (POST) state. The new A-site peptidyl-tRNA and P-site deacylated tRNA move to the P and E sites, respectively. This protein coordinates tRNA and mRNA movement, along with ribosomal conformational changes.
Database Links
Protein Families
TRAFAC class translation factor GTPase superfamily, Classic translation factor GTPase family, EF-G/EF-2 subfamily
Subcellular Location
Cytoplasm.

Q&A

What is Recombinant Clostridium botulinum Elongation factor G (fusA) and its function?

Recombinant Clostridium botulinum Elongation factor G (fusA) is a laboratory-produced version of a bacterial protein that naturally functions in protein synthesis. The native elongation factor G promotes the translocation step during protein synthesis in bacteria and, together with ribosome recycling factor (frr), dissociates ribosomes from messenger RNA after translation termination . This recombinant protein is produced using recombinant DNA technology to express the fusA gene from C. botulinum in a suitable host system such as baculovirus .

Research methodology for functional studies typically includes:

  • In vitro translation assays with purified components

  • GTPase activity measurements (as EF-G is a GTPase)

  • Ribosome binding and translocation studies

What are the standard specifications for commercial Recombinant C. botulinum fusA?

Commercial preparations of Recombinant C. botulinum Elongation factor G typically have the following specifications:

ParameterSpecificationNotes
Purity>85%As determined by SDS-PAGE
SourceBaculovirus expression systemFor proper protein folding
Storage-20°C (short-term), -20°C to -80°C (long-term)Avoid repeated freeze-thaw cycles
Uniprot No.A7FZ72From C. botulinum strain ATCC 19397 / Type A

How does fusA expression system selection impact protein functionality?

The expression system significantly impacts the quality and functionality of recombinant fusA protein. While baculovirus systems are commonly used for C. botulinum fusA production , researchers should consider:

  • Baculovirus systems: Offer superior folding for complex proteins, important for maintaining GTPase activity

  • E. coli systems: Can provide higher yields but may require optimization for proper folding, similar to approaches used for other C. botulinum recombinant proteins

  • Yeast systems: Like Pichia pastoris used for botulinum neurotoxin fragments , may provide beneficial post-translational modifications

When selecting an expression system, researchers should conduct activity assays to verify that the produced fusA maintains translocation-promoting functions similar to the native protein.

How can fusA be utilized in studying C. botulinum pathogenesis?

While fusA primarily functions in translation, its potential role in pathogenesis can be explored through:

  • Correlation studies: Analyzing relationships between fusA expression levels and toxin production under various growth conditions

  • Gene manipulation experiments: Studying the effects of fusA overexpression or knockdown on:

    • Growth kinetics

    • Stress tolerance

    • Toxin gene expression and secretion

    • Virulence in model systems

Evidence suggests that in other bacteria, modulation of translation machinery components can affect virulence factor production. For example, overexpression of fusA and frr in Corynebacterium glutamicum altered transcriptional levels of multiple metabolic pathway genes , suggesting similar approaches could reveal connections between translation efficiency and botulinum neurotoxin production.

What techniques are effective for detecting and measuring fusA expression in C. botulinum?

Researchers can employ several complementary techniques to detect and quantify fusA expression:

TechniqueApplicationAdvantagesConsiderations
RT-PCRmRNA quantificationHigh sensitivity, specificDoesn't confirm protein production
RNA-SeqTranscriptome-wide expressionProvides context within gene networksRequires sophisticated analysis
Western blottingProtein detectionConfirms translationRequires specific antibodies
Mass spectrometryProtein identification/quantificationHighly specificRequires specialized equipment

For RNA-seq analysis, researchers can adapt protocols described for bacterial transcriptomics, including rRNA depletion, library preparation with QIAseq stranded Total RNA Lib kit, and data analysis using network clustering algorithms like Map equation to identify co-regulated genes .

How can fusA research contribute to botulinum neurotoxin detection methods?

Recombinant fusA can be incorporated into comprehensive C. botulinum detection strategies:

  • Development of molecular detection tools:

    • Design of PCR primers targeting fusA as a species marker

    • Creation of molecular standards for qPCR assays

  • Immunological detection approaches:

    • Production of anti-fusA antibodies for use in ELISA or immunochromatographic assays

    • Development of multiplex assays combining detection of fusA and neurotoxin genes

These approaches could complement existing detection methods like DIG-ELISA, real-time PCR, and mouse bioassays currently used for C. botulinum detection in environmental samples .

What is the relationship between fusA function and botulinum neurotoxin production?

While direct evidence linking fusA to neurotoxin production is limited, several research approaches can explore this relationship:

  • Correlation analysis: Monitor fusA expression and neurotoxin production under various growth conditions

  • Translation efficiency studies: Investigate whether fusA activity affects translation of neurotoxin genes differently than housekeeping genes

  • Comparative genomics: Analyze fusA sequence variations across strains with different toxin production levels

Researchers could adapt methodologies from studies demonstrating that overexpression of translation factors can alter gene expression profiles to examine effects specifically on neurotoxin genes.

What protocols are recommended for verifying the activity of Recombinant C. botulinum fusA?

To verify functional activity of recombinant fusA, researchers should employ multiple complementary assays:

GTPase Activity Assay Protocol:

  • Prepare reaction buffer: 50 mM Tris-HCl (pH 7.5), 10 mM MgCl₂, 100 mM KCl

  • Incubate 1-5 μg of purified fusA with 1 mM GTP at 37°C

  • At timed intervals (0, 5, 10, 15, 30 min), remove aliquots and measure inorganic phosphate release using malachite green assay

  • Plot phosphate release over time to determine GTPase activity rate

Ribosome Binding Assay:

  • Isolate 70S ribosomes from E. coli or C. botulinum

  • Label fusA with fluorescent tag or radioisotope

  • Incubate labeled fusA with ribosomes in binding buffer

  • Separate bound from unbound fusA using ultracentrifugation through sucrose cushion

  • Quantify bound fusA through fluorescence measurement or scintillation counting

These functional assays provide evidence that the recombinant protein maintains its native activity.

How can researchers design experiments to study fusA interactions with other translation factors?

To investigate interactions between fusA and other translation components:

Pull-down Assay Protocol:

  • Express His-tagged fusA in appropriate expression system

  • Prepare bacterial lysate containing potential interaction partners

  • Incubate purified His-tagged fusA with Ni-NTA resin

  • Add bacterial lysate and incubate (4°C, 2-4 hours)

  • Wash extensively to remove non-specific binding

  • Elute bound proteins with imidazole buffer

  • Analyze by SDS-PAGE and mass spectrometry to identify interaction partners

Surface Plasmon Resonance Protocol:

  • Immobilize fusA on CM5 sensor chip via amine coupling

  • Prepare concentration series of potential binding partners (e.g., ribosome recycling factor, ribosomes)

  • Flow solutions over the sensor chip at controlled rate

  • Measure association and dissociation kinetics

  • Calculate binding constants (KD, ka, kd)

These approaches allow quantitative measurement of protein-protein interactions important for translation.

What are the best approaches to study fusA function under stress conditions relevant to C. botulinum?

To investigate fusA's role under stress conditions:

Stress Response Transcriptomics Protocol:

  • Culture C. botulinum under various stress conditions (acid, heat, high pressure processing)

  • Extract total RNA using hot phenol method or commercial kits

  • Deplete rRNA and prepare RNA-seq libraries

  • Sequence on appropriate platform

  • Analyze differential expression of fusA and co-regulated genes

  • Construct gene networks to identify stress-response modules

Protein Stability Assay:

  • Express recombinant fusA

  • Expose to stress conditions (pH, temperature, pressure)

  • Measure activity retention over time

  • Analyze structural changes using circular dichroism or fluorescence spectroscopy

These methodologies help elucidate how fusA function may change during stress conditions that C. botulinum encounters in food processing environments.

How can fusA research contribute to vaccine development against C. botulinum?

While fusA itself is not typically a vaccine target, research methodologies from fusA studies can inform botulinum vaccine development:

  • Expression system optimization: Techniques refined for fusA expression can be applied to neurotoxin fragment production

  • Protein folding validation: Methods for verifying fusA folding can be adapted for recombinant vaccine candidates

  • Adjuvant compatibility studies: Protein stability testing protocols can assess vaccine antigen stability with various adjuvants

The approaches used for developing recombinant fusion vaccines against botulinum neurotoxins could potentially incorporate insights from fusA expression and stability studies.

What are the challenges in developing fusA-based detection systems for C. botulinum?

Development of fusA-based detection systems faces several challenges:

ChallengeSolution ApproachConsiderations
Cross-reactivity with other ClostridiaIdentify unique fusA epitopes or sequencesRequires comparative genomic analysis
Sensitivity limitationsImplement signal amplification methodsMay need to combine with toxin detection
Sample preparation complexityOptimize DNA/RNA extraction protocolsMust work with diverse sample types
Validation requirementsCompare with gold standard methodsShould correlate with mouse bioassay results

Researchers could adapt the multi-method approach described for C. botulinum detection in water samples , incorporating fusA-specific targets alongside existing neurotoxin gene targets.

How might comparative analysis of fusA across C. botulinum strains advance understanding of translation efficiency?

Future research directions could include:

  • Comparative sequence analysis: Identify strain-specific variations in fusA that correlate with growth rates or toxin production

  • Structure-function studies: Determine how specific amino acid changes affect fusA GTPase activity and ribosome interaction

  • Translation kinetics measurement: Develop methods to quantify differences in translation elongation rates across strains

These approaches could yield insights into whether translation efficiency differences contribute to strain-specific variations in toxin production or environmental persistence.

What novel methodologies could advance the study of fusA regulation in C. botulinum?

Emerging technologies with potential application to fusA research include:

  • CRISPR-Cas9 genome editing: For precise manipulation of fusA expression in C. botulinum

  • Ribosome profiling: To measure translation efficiency of specific mRNAs in relation to fusA activity

  • Single-cell analyses: To investigate cell-to-cell variation in fusA expression within C. botulinum populations

  • Cryo-electron microscopy: For structural studies of fusA-ribosome interactions

Developing these methodologies specifically for C. botulinum would overcome current limitations in understanding fusA regulation and function in this important pathogen.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.